Home / Musculoskeletal system / Febuxostat
ATC M04AA03 · Antigout Preparations
Febuxostat shortage
As of 31 Oct 2026, Febuxostat has a reported shortage in 3 of the 5 countries we track (Italy, Austria, Belgium), covering 7 products.
Countries3/5
Products7packs or presentations
Short since17 Feb 202520 months ago
Earliest return30 Nov 2026company estimate
No return date5products
Main reasonManufacturing problem
Timeline
ItalyAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | FEBUXOSTAT VIATRIS | VIATRIS LIMITED | 17 Feb 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | FEBUXOSTAT VIATRIS | VIATRIS LIMITED | 1 Jun 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | FEBUXOSTAT TEVA | TEVA B.V. | 16 Mar 2026 | 30 Nov 2026 | Manufacturing problem Problemi produttivi |
| IT | FEBUXOSTAT AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 20 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| AT | Febuxostat Sandoz 80 mg - Filmtabletten, 14 Stück | Sandoz GmbH | 19 Jun 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Febuxostat ratiopharm 120 mg Filmtabletten, 30 Stück | Teva B.V. | 17 Aug 2026 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
| BE | Febuxostat AB 80 mg film-coat. tabl. 84 | Aurobindo | 19 Jun 2026 | 31 Jan 2027 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.